Novo Nordisk A/S (NYSE:NVO – Get Free Report) shares were down 6.1% on Tuesday . Key Novo Nordisk A/S NewsHere are the key news stories impacting Novo Nordisk A/S this week:Get Novo Nordisk A/S alerts:Analysts Set New Price TargetsNVO has been the subject of several research reports. As a group, equities analysts anticipate that Novo Nordisk A/S will post 3.38 EPS for the current year. Price T Rowe Associates Inc. MD grew its holdings in Novo Nordisk A/S by 99.7% in the fourth quarter. Further ReadingReceive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter.